Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abbott Laboratories (ABT) vs Costco Wholesale Corporation (COST) Price & Performance

Abbott Laboratories
Costco Wholesale Corporation

Price performance

Price movement over the last 24 hours

Key statistics

Abbott Laboratories vs Costco Wholesale Corporation — how do they compare? Abbott Laboratories trades at $95.23 (market cap $166.94B), while Costco Wholesale Corporation trades at $954.19 (market cap $420.20B). The key difference: Costco Wholesale Corporation is far larger — about 2.5× Abbott Laboratories's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.

ABTCOST
Market Cap
$166.94B$420.20B
Sector
HealthConsumer Staples
52-Week High
$136.62$1.09K
52-Week Low
$82.57$849.63
Enterprise Value
$193.69B$408.34B
Dividend Yield
2.63%0.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abbott Laboratories

Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.

The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.

Costco Wholesale Corporation

Costco (COST) trades at $953.55, up 0.35% with a bearish technical signal despite strong fundamentals. The company reported solid March sales growth of 11.3% year-over-year and maintains consistent revenue and earnings growth. Analyst consensus remains strongly bullish with 65.5% buy ratings and a $1,110 price target, though valuation metrics appear elevated with a P/E of 47.7.

The stock faces near-term technical pressure but benefits from strong membership fee growth and expanding profitability. Key risks include premium valuation compression and competitive pressures, while catalysts include sustained membership renewal strength and international expansion opportunities.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Read more on ABT

About Costco Wholesale Corporation

The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet

Read more on COST